New study finds that a salivary peptide from mosquitoes — sialokinin — binds human neurokinin receptors and dampens monocyte activation, reducing inflammation during Chikungunya virus infection. 🔬 Interestingly: • Sialokinin triggers PI3K/Akt signalling via NK₁R/NK₂R in
0
4
13